Prevalence of <i>Wb</i> microfilaremia and circulating filarial antigenemia before and after MDA in annual and semiannual intervention areas. by Michael C. Payne (2664379)

Subjects:

Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic for males. by Dainty Ei (22265317)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2022. by Dainty Ei (22265317)

Subjects:

Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. by Michael C. Payne (2664379)

Subjects:

Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic (both genders). by Dainty Ei (22265317)

Subjects:

Fixed-effects panel regression results for nicotine dependence drug prescribing. by Dainty Ei (22265317)

Subjects:

The incidence and mortality data of LC by age group from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2021. by Dainty Ei (22265317)

Subjects:

Population as of 1 November, number by age, sex, year, and region. by Dainty Ei (22265317)

Subjects:

Sentinel sites located within areas treated with MDA semiannually (solid red line) or annually (dashed blue line). by Michael C. Payne (2664379)

Subjects:

Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Directly observed antifilarial drug ingestion rates in semiannual and annual mass drug administration (MDA) areas. by Michael C. Payne (2664379)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2020. by Dainty Ei (22265317)

Subjects:

Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr)... by Michael C. Payne (2664379)

Subjects:

Contribution of changes in population aging, population growth, and age-specific incidence rate to changes in incident cases of LC from 2004 to 2018 in China. by Ze-Xing Zhang (18074512)

Subjects:

Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis by Lin Y.-T. (17065287)

“…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …”

Risk of acquiring SARS-CoV-2 infection in the household (children vs. adults). by Jesús Poch-Páez (21807825)

Subjects:

Correlation and median comparison. ACE2 and TMPRSS2 expression. by Jesús Poch-Páez (21807825)

Subjects:

Correlation between age and ACE2ACE2 and TMPRSS2 protease expression. by Jesús Poch-Páez (21807825)

Subjects: